Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Tetanus × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Brain Neoplasms 1543 Glioblastoma 1180 Glioma 909 Neuroblastoma 367 Central Nervous System Neoplasms 349 Astrocytoma 347 Gliosarcoma 270 Oligodendroglioma 223 Neoplasms 206 Breast Neoplasms 195 Meningioma 166 Medulloblastoma 150 Recurrence 131 Carcinoma, Non-Small-Cell Lung 131 Neoplasm Metastasis 122 Lung Neoplasms 121 Ependymoma 120 Melanoma 108 Sarcoma 107 Neurofibromatosis 1 100 Meningeal Carcinomatosis 98 Lymphoma 85 Diffuse Intrinsic Pontine Glioma 75 Neuroma, Acoustic 73 Precursor Cell Lymphoblastic Leukemia-Lymphoma 71 Head and Neck Neoplasms 66 Ovarian Neoplasms 65 Lymphoma, Follicular 64 Wilms Tumor 62 Lymphoma, Non-Hodgkin 62

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡